Page 11 - Pharmaceutical
Intrexon & Johnson Matthey team up for production of peptide-based APIs
Though peptide-based APIs are highly useful, they are often costly & difficult to produce
 "Intrexon & Johnson Matthey team up for production of peptide-based APIs")
Soon, Jan Aushadhi stores to open at railway stations
Govt plans to utilise railway's infrastructure to increase accessibility of affordable generic drugs
 "Soon, Jan Aushadhi stores to open at railway stations")
Italian firm Olon buys Ricerca Biosciences' chemical division
Acquisition strengthens service offering of Olon SpA for research and manufacturing
 "Italian firm Olon buys Ricerca Biosciences' chemical division")
Unichem Laboratories aims $ 100 mn revenue from US
For this, the company will focus on differentiated complex generics, which are difficult to produce
 "Unichem Laboratories aims $ 100 mn revenue from US")
JSR Corp arm KBI Biopharma to invest $ 30 mn to expand two facilities in US
It will expand biopharmaceutical manufacturing capacity at both its Durham and Boulder facilities
 "JSR Corp arm KBI Biopharma to invest $ 30 mn to expand two facilities in US")
Bal Pharma to close down parenterals & IV fluids facility at Pune
Decision was taken as part of its restructuring exercise undertaken to streamline its operations
 "Bal Pharma to close down parenterals & IV fluids facility at Pune")
Pharmaceutical packaging equipment market to reach $ 8.24 billion by 2022
Need for stringent regulatory compliances is driving this market, says MarketsandMarkets report
 "Pharmaceutical packaging equipment market to reach $ 8.24 billion by 2022")
Alivira's animal health API facility gets US FDA approval
Approval will enable SeQuent Scientific arm to enter the $ 8-bn US veterinary healthcare market
 "Alivira's animal health API facility gets US FDA approval")
Govt's aim is to make IPR policy more efficient: Nirmala Sitharaman
India's IPR policy is TRIPS compliant and forward looking, says the Minister of Commerce & Industry
 "Govt's aim is to make IPR policy more efficient: Nirmala Sitharaman")
Glenmark starts clinical trial for biosimilar used to treat allergic asthma
The reference product for this biosimilar is omalizumab, sold under the brand name Xolair
 "Glenmark starts clinical trial for biosimilar used to treat allergic asthma")
Amgen & Novartis expand collaboration for migraine drug Erenumab
It builds on their global neuroscience partnership in Alzheimer's disease & migraine formed in 2015
 "Amgen & Novartis expand collaboration for migraine drug Erenumab")
Merck sells biosimilars business to Fresenius to focus on innovative drugs
Merck to receive upfront payment of € 170 mn & milestone payments of up to € 500 mn on future sales
 "Merck sells biosimilars business to Fresenius to focus on innovative drugs")
US FDA issues warning letter for Divi's Laboratories' Visakhapatnam unit
Last month, US drug regulator had issued an import alert on the products manufactured from this unit
 "US FDA issues warning letter for Divi's Laboratories' Visakhapatnam unit")
Avantor Performance Materials acquires Puritan Products
Deal to enhance Avantor's portfolio of high-purity cGMP materials & solutions for biopharma industry
 "Avantor Performance Materials acquires Puritan Products")
Sawai Pharmaceutical buys Upsher?Smith's generics business for $1.05 bn
The acquisition will mark a major expansion of Sawai's presence in the US market
 "Sawai Pharmaceutical buys Upsher?Smith's generics business for $1.05 bn")
BioInvent to use Merck's bioreactors to expand Swiss facility
Addition of single-use Mobius bioreactors to streamline BioInvent's drug development & production
 "BioInvent to use Merck's bioreactors to expand Swiss facility")
Bain Capital & Cinven buy German generic drug maker Strada for € 4.1 bn
Stada offers a portfolio of high-quality, low-cost generic products including selected biosimilars
 "Bain Capital & Cinven buy German generic drug maker Strada for € 4.1 bn")
Winning strategies for companies to succeed in ever-changing pharma market
Pharma leaders need to take swift steps to get ahead of emerging changes, says Utkarsh Palnitkar
 "Winning strategies for companies to succeed in ever-changing pharma market")
Cipla to collaborate with US-based MEDRx for muscle relaxant drug
As per the deal, MEDRx to receive upfront payment of about $ 30 mn & will be eligible for royalties
 "Cipla to collaborate with US-based MEDRx for muscle relaxant drug")
IoT can help pharma industry to overcome quality challenges: Study
Assocham-Sathguru joint study urges government to reduce the dependency on China for APIs
 "IoT can help pharma industry to overcome quality challenges: Study")
